Research Achievements 研究支援実績

掲載論文

• 【2026】
  Kobayashi T, Yamada K, Yamaguchi S, Ishibashi H, Arai T, Morita Y, Ito YM, Morimoto T, Ohe T, Nakagawa R.
  Bodyweight increase since early adulthood as a risk factor for mobility decline: a 7-year longitudinal study of 10,316 Japanese adults aged ≥40 years.
  Archives of Public Health, 2026.
  DOI: 10.1186/s13690-025-01829-4

  【2025】
  Tsuboi J, Eguchi A, Inoue H, Ichishi M, Go M, Okajima R, Yasuhara N, Nakagawa R, Tempaku M, Izuoka K, Tanaka T, Nose K, Yoshizawa N, Hirokawa Y, Yamada R, Tanaka K, Kawamura T, Yamaguchi T, Takei Y, Iwasa M, Yamashita T, Watanabe M, Nakagawa H.
  Plexin Domain Containing 2, a Protein Specifically Expressed and Elevated in Human Pancreatic Cancer Tissue and Serum, Influences Cell Proliferation by Correlating With Cortactin.
  Cancer Medicine, 2025.
  DOI: 10.1002/cam4.71459

  Iwasa M, Eguchi A, Tamai Y, Shigefuku R, Tanaka H, Nakagawa R, Tempaku M, Kobayashi Y, Nakagawa H.
  Elevation of Immunoglobulin Free Light Chain and BAFF Levels Associated With Immune Activation Predicts Survival Rates in Chronic Liver Disease.
  Hepatology Research, 2025.
  DOI: 10.1111/hepr.70009

  Zhang J, Nakagawa R, Xu Q, Hu K, Ru L, Nakagawa H, Hirata Y.
  Dendritic Cell-Depleted Mice Develop the Autoimmune Biliary Disease That Serologically and Pathogenically Models Human Primary Biliary Cholangitis.
  Hepatology Research, 2025.
  DOI: 10.1111/hepr.70005

  Qiang N, Ao J, Nakamura M, Katayama K, Zhang J, Kogure T, Ogawa K, Nakagawa R, et al.
  MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma.
  Biochemical Pharmacology, 2025.
  DOI: 10.1016/j.bcp.2024.116829

  Goto C, Maruya K, Morita Y, Arai T, Yamaguchi S, Yamada K, Moriyama M, Ishibashi H, Nakagawa R.
  Prevalence and coexistence of locomotive syndrome with reduced mobility and metabolic syndrome: a cross-sectional study of 35,059 Japanese adults.
  Scientific Reports, 2025.
  DOI: 10.1038/s41598-025-98288-2

  【2024】
  Komatsu K, Sano K, Fukai K, Nakagawa R, Nakagawa T, Tatemichi M, Nakano T.
  Standardized evaluation of diabetic retinopathy using artificial intelligence and its association with metabolic dysfunction-associated steatotic liver disease in Japan.
  PLoS ONE, 2024.
  DOI: 10.1371/journal.pone.0315752

  Ao J, Qiang N, Kanzaki H, Nakamura M, Kakiuchi R, Zhang J, Kojima R, Koroki K, Inoue M, Kanogawa N, Nakagawa R, Kondo T, Ogasawara S, Nakamoto S, Muroyama R, Kato J, Kato N.
  Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis.
  American Journal of Physiology – Cell Physiology, 2024.
  DOI: 10.1152/ajpcell.00511.2024

  【2023】
  Komatsu K, Sano K, Fukai K, Nakagawa R, Nakagawa T, Tatemichi M, Nakano T.
  Associated factors of diabetic retinopathy by artificial intelligence evaluation of fundus images in Japan.
  Scientific Reports, 2023.
  DOI: 10.1038/s41598-023-47270-x

  Nagashima A, Okimoto K, Nakagawa R, Akizue N, Matsumura T, Oura H, et al.
  Investigation of risk factors for metachronous recurrence in patients with early gastric adenocarcinoma by miRNA–mRNA integral profiling.
  Scientific Reports, 2023.
  DOI: 10.1038/s41598-023-47000-3

  Tsutsui K, Nemoto M, Kono M, Sato T, Yoshizawa Y, Yumoto Y, Nakagawa R, et al.
  GC-MS analysis of exhaled gas for fine detection of inflammatory diseases.
  Analytical Biochemistry, 2023.
  DOI: 10.1016/j.ab.2023.115155

  Seimiya T, Suzuki T, Iwata T, Kishikawa T, Sekiba K, Shibata C, Ishigaki K, Fujiwara H, Oyama H, Kanai S, Sato T, Nakai Y, Ishibashi R, Moriyama M, Nakagawa R, Ijichi H, Otsuka M, Koike K.
  Combination of serum human satellite RNA and miR-21-5p levels as a biomarker for pancreatic cancer.
  iScience, 2023.
  DOI: 10.1016/j.isci.2023.106021

  【2003】
  Enomoto T, Usuki J, Azuma A, Nakagawa T, Kudoh S.
  Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis.
  Chest, 2003; 123(6): 2007–2011.
  DOI: 10.1378/chest.123.6.2007